Local anaesthetic sympathetic blockade for complex regional pain syndrome

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 8, 2013, Pages

  Stanton, Tasha R ^a,b   Wand, Benedict M ^c   Carr, Daniel B ^d   Birklein, Frank ^e   Wasner, Gunnar L ^f   O'connell, Neil E ^g  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF NOTRE DAME   (Australia)

^d TUFTS MEDICAL CENTER   (United States)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

^g BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BUPIVACAINE; CLONIDINE; GUANETHIDINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; PHENTOLAMINE; PLACEBO;

ADVERSE EVENT; ANALGESIA; BLURRED VISION; COMPLEX REGIONAL PAIN SYNDROME; DIZZINESS; DROWSINESS; DRUG EFFICACY; HEADACHE; HOARSENESS; HUMAN; INCIDENCE; INJECTION SITE PAIN; NAUSEA; OUTCOME ASSESSMENT; PAIN INTENSITY; PARESTHESIA; PRIORITY JOURNAL; REHABILITATION CARE; REVIEW; SYMPATHETIC BLOCKING; SYSTEMATIC REVIEW; VOMITING; XEROSTOMIA; ADULT; CAUSALGIA; CHILD; COMPLEX REGIONAL PAIN SYNDROME TYPE I; META ANALYSIS; METHODOLOGY; NERVE BLOCK; RANDOMIZED CONTROLLED TRIAL (TOPIC); COMPLEX REGIONAL PAIN SYNDROMES; PROCEDURES; REFLEX SYMPATHETIC DYSTROPHY;

ADULT; ANESTHETICS, LOCAL; AUTONOMIC NERVE BLOCK; CAUSALGIA; CHILD; COMPLEX REGIONAL PAIN SYNDROMES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFLEX SYMPATHETIC DYSTROPHY;

EID: 84892796565     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004598.pub3     Document Type: Review

References (103)

1. Aydemir K, Taskaynatan MA, Yazicloglu K, Ozgul A. The effects of stellate ganglion block with lidocaine and ultrasound in complex regional pain syndrome: A randomized, double blind, placebo controlled study. Journal of Rheumatology and Medical Rehabilitation 2006;17:193-200.
2. Bonelli S, Conoscente F, Movilia PG, Restelli L, Francucci B, Grossi E. Regional intravenous guanethidine vs. stellate ganglion block in reflex sympathetic dystrophies: a randomized trial. Pain 1983;16:297-307.
3. Carroll I, Clark J D, Mackey S. Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Annals of Neurology 2009;65(3):348-51.
4. Meier PM, Zurakowski D, Berde CB, Sethna NF. Lumbar sympathetic blockade in children with complex regional pain syndromes: a double blind placebo-controlled crossover trial. Anesthesiology 2009;111(2):372-80.
5. Nascimento MSA, Klamt JG, Prado WA. Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I. Brazilian Journal of Medical and Biological Research 2010;43(12):1239-44.
6. Price DD, Long S, Wilsey B, Rafii A. Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients. Clinical Journal of Pain 1998;14:216-26.
7. Raja SN, Treede RD, Davis KD, Campbell JN. Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiology 1991;74:691-8.
8. Rodriguez RF, Bravo LE, Tovar MA, Castro F, Ramos GE, Mendez F. Determination of the analgesic efficacy of the stellate ganglion blockade in the alleviation of pain mediated by the sympathetic nervous system in patients with Complex Regional Pain Syndrome [Determinacion de la eficacia analgesica de los bloqueos del ganglio estrellado en el alivio del dolor mediado por el sistema nervioso simpatico, en pacientes con sindrome doloroso regional complejo del miembro superior]. Revista Colombiana de Anestetica 2005;33(3):153-9.
9. Toshniwal G, Sunder R, Thomas R, Dureja GP. Management of complex regional pain syndrome type I in upper extremity - Evaluation of continuous stellate ganglion block and continuous infraclavicular brachial plexus block: A pilot study. Pain Medicine 2012;13:96-106.
10. Verdugo RJ, Moya MF, Cea JG, Salinas HA, Bilbeny CJ. Stellate ganglion block in reflex sympathetic dystrophy: a double-blind crossover study. Program & Abstracts of the 1st Scientific Meeting of the European Federation of IASP Chapters. 1995.
11. Wehnert Y, Müller B, Larsen B, Kohn D. [Sympathetically maintained pain (SMP): phentolamine test vs sympathetic nerve blockade. Comparison of two diagnostic methods]. Der Orthopäde 2002;31:1076-83.
12. Zeng X, Chen S, Guan C, Jiang L, Wang L. Block of ganglion stellatum on improving edema and range of movement in shoulder-hand syndrome. Chinese Journal of Clinical Rehabilitation 2003;7(7):1194-5.
13. Ackerman WE, Zhang JM. Efficacy of stellate ganglion blockade for the management of type 1 complex regional pain syndrome. Southern Medical Journal 2006;99(10):1084-8.
14. Arias LM, Bartkowski R, Grossman KL, Schwartzman RJ, Tom CM. Sufentanil stellate ganglion injection in the treatment of refractory reflex sympathetic dystrophy. Regional Anesthesia 1989;14(2):90-2.
15. Catala E, Ferrandiz M, Aliaga L, Serra R, Castro MA, Villar JM. Intravenous lidocaine compared with sympathetic blocks as treatment for post-herpetic neuralgia. A 1-year survey. The Pain Clinic 1994;7(3):205-10.
16. Dellemijn PL, Fields HL, Allen RR, McKay WR, Rowbotham MC. The interpretation of pain relief and sensory changes following sympathetic blockade. Brain 1994;117:1475-87.
17. Erickson SJ, Hogan QH. CT-guided injection of the stellate ganglion: Description of technique and efficacy of sympathetic blockade. Radiology 1993;188:707-9.
18. Farcot JM, Grasser C, Foucher G, Marin Braun F, Ehrler S, Demangeat JL, et al.[Local intravenous treatment of algodystrophy of the hand: buflomedil versus guanethidine, long term follow-up]. Annales de chirurgie de la main et du membre supérieur: organe officiel des sociétés de chirurgie de la main 1990;9:296-304.
19. Fukusaki M, Matsumoto M, Yamaguchi K, Nakamura H, Sumiwaka K. The role of nerve blocks to deal with pain associated with cervical radiculopathy. The Pain Clinic 1995;8(3):219-25.
20. Garrido B, Fernandez-Suarez L, Bosch F, Rabi MC, Hernandez-Arteaga M. Complex regional pain syndrome type I. Management with sympathetic blockade and other therapies. Revista de la Sociedad Espanola del Dolor 2005;12(7):417-24.
21. Geurts J. Percutaneous sympathetic blockade in complex regional pain syndrome type 1: a prospective clinical investigation on predictors of sympatheticaly maintained pain ID - 7. Controlled trials register ISRCTN. Controlled trials register ISRCTN (www.controlled-trials.com/isrctn), 2006.
22. Glynn C, Casale R. Morphine injected around the stellate ganglion does not modulate the sympathetic nervous system nor does it provide pain relief. Pain 1993;53(33):37.
23. Hartrick CT, Kovan JP, Naismith P. Outcome prediction following sympathetic block for complex regional pain syndrome. Pain Practice 2004;4:222-8.
24. Linson MA, Leffert R, Todd DP. The treatment of upper extremity reflex sympathetic dystrophy with prolonged continuous stellate ganglion blockade. Journal of Hand Surgery 1983;8:153-9.
25. Malmqvist ELA, Bengtsson M, Sorensen J. Efficacy of stellate ganglion block: A clinical study with bupivacaine. Regional Anesthesia 1992;17:340-7.
26. Perrigot M, Bergego C, Hocini A, Pierrot Deseilligny E. Algodystrophic syndrome in hemiplegia. Clinical and therapeutic study [Le syndrome algodystrophique chez l'hémiplégique. Etude clinique et thérapeutique]. Annales de Médecine Interne 1982;133:544-8.
27. Quevedo JP, Purgavie K, Platt H, Strax TE. Complex regional pain syndrome involving the lower extremity: a report of 2 cases of sphenopalatine block as a treatment option. Archives of Physical Medicine and Rehabilitation 2005;86(2):335-7.
28. Rodriguez RF, Bravo LE, Tovar MA, Castro F, Ramos GE, Daza P. Study of the analgesic efficacy of stellate ganglion blockade in the management of the complex regional pain syndrome in patients with pain mediated by sympathetic nervous system: Preliminary study. Revista de la Sociedad Espanola del Dolor 2006;13(4):230-7.
29. Rodriguez RF, Bravo LE, Tovar MA, Ramos GE. Sympathetic blockades in sympathetic mediated pain. International Association for the study of Pain (IASP) Conference proceedings, Glasgow, Scotland. 2008:PM 349.
30. Salinas Cerda, H. Reflex sympathetic dystrophy: long-term control of sympatic block with guanethidine [Distrofia simpática refleja: control a largo plazo del bloqueo simpático con guanetidina]. Dolor 1997;5:17-22.
31. Schurmann M, Gradl G, Wizgal I, Tutic M, Moser C, Azad S, et al. Clinical and physiologic evaluation of stellate ganglion blockade for complex regional pain syndrome type I. Clinical Journal of Pain 2001;17:94-100.
32. Steinbrocker O, Neustadt D, Lapin L. Shoulder-hand syndrome: Sympathetic block compared with corticotropin and cortisone therapy. Journal of the American Medical Association 1953;153(9):788-91.
33. Tran KM, Frank SM, Raja SN, El Rahmany HK, Kim LJ, Vu B. Lumbar sympathetic block for sympathetically maintained pain: changes in cutaneous temperatures and pain perception. Anesthesia and Analgesia 2000;90:1396-401.
34. Wang JK, Erickson RP, Ilstrup DM. Repeated stellate ganglion blocks for upper-extremity reflex sympathetic dystrophy. Regional Anesthesia 1985;10:125-8.
35. Yucel I, Demiraran Y, Ozturan K, Degirmenci E. Complex regional pain syndrome type I: efficacy of stellate ganglion blockade. Journal of Orthopaedic Traumatology 2009;10(4):179-83.
36. Rocha RO. RCT: Thoracic sympathetic block for the treatment of complex regional pain syndrome I of the upper limb. ID - 7. ClinicalTrials.gov. Sao Paulo, 2012:Identifier: NCT01612364. Available at: http://clinicaltrials.gov/ct2/show/NCT01612364.
37. Albrecht PJ, Hines S, Eisenberg E, Pud D, Finlay DR, Davar G, et al. Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome. Pain 2006;120:244-66.
38. Ali Z, Raja SN, Wesselmann U, Fuchs PN, Meyer RA, Campbell JN. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain 2000;88(2):161-8.
39. Altman DG, Moher D, Schultz KF. Improving the reporting of randomised trials: The CONSORT statement and beyond. Statistics in Medicine 2012;31(25):2985-97.
40. Binder A, Baron R. Complex regional pain syndrome, including applications of neural blockade. In: Cousins MJ, Carr DB, Horlocker TT, Bridenbaugh PO editor(s). Cousins & Bridenbaugh's Neural Blockade in Clinical Anesthesia and Management of Pain. 4th Edition. Philadelphia: Lippincott Williams & Wilkins, 2009:1154-1168.
41. Birklein F, Weber M, Neundörfer B. Increased skin lactate in complex regional pain syndrome: Evidence for tissue hypoxia?. Neurology 2000;55(8):1213-5.
42. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 2001;57:2179-84.
43. Breivik H, Cousins MJ. Sympathetic neural blockade of upper and lower extremity. Chapter 39. In: Cousins MJ, Carr DB, Horlocker TT, Bridenbaugh PO editor(s). Cousins & Bridenbaugh's Neural Blockade in Clinical Anesthesia and Management of Pain. 4th Edition. Philadelphia: Lippincott Williams & Wilkins, 2009:848-885.
44. Bruehl S, Harden RN, Galer BS, Saltz S, Bertram M, Backonja M, et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. Pain 1999;81:147-54.
45. Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology 2010;113(3):713-25.
46. Campbell JN. Complex regional pain syndrome and the sympathetic nervous system. Pain 1996;68:89-96.
47. Carr DB. Local anesthetic blockade for neuralgias: "why is the sky blue, daddy?". Anesthesia and Analgesia 2011;112:1285.
48. De Mos M, De Bruijn AGJ, Huygen FJPM, Dieleman JP, Stricker BHC, Sturkenboom MCJM. The incidence of complex regional pain syndrome: a population-based study. Pain 2007;129(1-2):12-20.
49. De Mos M, Huygen FJPM, Dieleman JP, Koopman JSHA, Stricker BHC, Sturkenboom MCJM. Medical history and the onset of complex regional pain syndrome (CRPS). Pain 2008;139(2):458-66.
50. De Mos, Sturkenboom MCJM, Huygen FJPM. Current understandings on complex regional pain syndrome. Pain Practice 2009;9(2):86-99.
51. Drummond PD, Finch PM, Skipworth S, Blockey P. Pain increases during sympathetic arousal in patients with complex regional pain syndrome. Neurology 2001;57(7):1296-303.
52. Drummond PD, Finch PM. Persistence of pain induced by startle and forehead cooling after sympathetic blockade in patients with complex regional pain syndrome. Journal of Neurology, Neurosurgery and Psychiatry 2004;75(1):98-102.
53. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008;9(2):105-21.
54. Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, et al. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain 2009;146(3):238-44.
55. Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, et al. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 2010;149(2):177-93.
56. Fine PG, Roberts WJ, Gillette RG, Child TR. Slowly developing placebo responses confound tests of intravenous phentolamine to determine mechanisms underlying idiopathic chronic low back pain. Pain 1994;56:235-42.
57. Forouzanfar T, Koke AJ, Van Kleef M, Weber WE. Treatment of complex regional pain syndrome type I. European Journal of Pain 2002; Vol. 6, issue 2:105-22.
58. Geha PY, Baliki MN, Harden RN, Bauer WR, Parrish TB, Apkarian AV. The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 2008;60(4):570-81.
59. Harden RN, Bruehl S. Introduction and diagnostic considerations. In: Harden RN editor(s). Complex regional pain syndrome: treatment guidelines. Reflex Sympathetic Dystrophy Syndrome Association, 2006.
60. Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Medicine 2013;14(2):180-229.
61. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
62. Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org.
63. Hogan QH, Abram SE. Neural blockade for diagnosis and prognosis. A review. Anesthesiology 1997;86:216-41.
64. Jadad AR, Carroll D, Glynn CJ, McQuay HJ. Intravenous regional sympathetic blockade for pain relief in reflex sympathetic dystrophy: a systematic review and a randomized, double blind crossover study. Journal of Pain and Symptom Management 1995;10:13-20.
65. Jänig W, Baron R. Complex regional pain syndrome: mystery explained?. Lancet Neurology 2003;2(11):687-97.
66. Koban M, Leis S, Schultze-Mosgau S, Birklein F. Tissue hypoxia in complex regional pain syndrome. Plastic and Reconstructive Surgery 2003;104:149-57.
67. Lewis JS, Kersten P, Mccabe CS, Mcpherson KM, Blake DR. Body perception disturbance: A contribution to pain in complex regional pain syndrome (CRPS). Pain 2007;133(1-3):111-9.
68. Lotze M, Moseley GL. Role of distorted body image in pain. Current Rheumatology Reports 2007;9(6):488-96.
69. Maihöfner C, Handwerker HO, Neundörfer B, Birklein F. Cortical reorganization during recovery from complex regional pain syndrome. Neurology 2004;63(4):693-701.
70. Marinus J, Moseley GL, Birklein F, Baron R, Maihofner C, Kingery WS, et al. Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurology 2011;10(7):637-48.
71. McQuay HJ, Moore RA, Eccleston C, Morley S, Williams AC. Systematic review of outpatient services for chronic pain control. Health Technology Assessment 1997;1(6):1-135.
72. Merskey H, Bogduk N. Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd Edition. Seattle: IASP Press, 1994.
73. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic reviews in pain research: methodology refined. Seattle: IASP Press, 2008:15-23.
74. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al."Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews. Pain 2010;150(3):386-9.
75. Moseley GL. Why do people with complex regional pain syndrome take longer to recognize their affected hand ?. Neurology 2006;62(12):2182-6.
76. Nelson DV, Stacey BR. Interventional therapies in the management of complex regional pain syndrome. Clinical Journal of Pain 2006;22(5):438-42.
77. Niehof SP, Huygen FJPM, Van der Weerd RWP, Westra M, Zijlstra FJ. Thermography imaging during static and controlled thermoregulation in complex regional pain syndrome type 1: diagnostic value and involvement of the central sympathetic system. BioMedical Engineering Online 2006;5:30.
78. Nüesch E, Trelle S, Reichenbach S, Rutjes AWS, Tschannen B, Altman DG, et al. Small study effects in meta-analyses of osteoarthritis trials: Meta-epidemiological study. BMJ 2010;341(7766):241.
79. Ochoa JL, Verdugo RJ. Reflex sympathetic dystrophy. A common clinical avenue for somatoform expression. Neurologic Clinics 1995;13:351-63.
80. Perez RS, Zollinger PE, Dijkstra PU, Thomassen-Hilgersom IL, Zuurmond WW, Rosenbrand KCJ, et al. Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurology 2010;10:20.
81. Pleger B, Ragert P, Schwenkreis P, Forster AF, Wilimzig C, Dinse H, et al. Patterns of cortical reorganization parallel impaired tactile discrimination and pain intensity in complex regional pain syndrome. Neuroimage 2006;32:503-10.
82. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
83. Sandroni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 2003;103(1-2):199-207.
84. Schinkel C, Gaertner A, Zaspel J, Zedler S, Faist E, Schuermann M. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clinical Journal of Pain 2006;22(3):235-9.
85. Schmelz M, Weber M, Birklein F, Neundo B. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 2001;91:251-7.
86. Schott GD. An unsympathetic view of pain. Lancet 1995;345:634-6.
87. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
88. Schwenkreis P, Janssen F, Rommel O, Pleger B, Volker B, Hosbach I, et al. Bilateral motor cortex disinhibition in complex regional pain syndrome (CRPS) type I of the hand. Neurology 2003;61:515-9.
89. Sethna NF. Sympathetic nerve blocks, pragmatic trials and responder analysis. Anesthesiology 2012;116(1):12-4.
90. Shipton EA. Complex regional pain syndrome: mechanisms, diagnosis, and management. Current Anaesthesia and Critical Care 2009;20:209-14.
91. Stanton-Hicks 1995. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 1995;63(1):127-33.
92. Stanton-Hicks MD, Burton AW, Bruehl SP, Carr DB, Harden RN, Hassenbusch SJ, et al. An updated interdisciplinary clinical pathway for CRPS: report of an expert panel. Pain Practice 2002;2(1):1-16.
93. Swart CMA, Stins JF, Beek PJ. Cortical changes in complex regional pain syndrome (CRPS). European Journal of Pain 2009;13(9):902-7.
94. Tan ECTH, Oyen WJG, Goris RJA. Leukocytes in complex regional pain syndrome type I. Inflammation 2005;29(4-6):182-6.
95. Tran DQH, Duong S, Bertini P, Finlayson R. Treatment of complex regional pain syndrome: A review of the evidence. Canadian Journal of Anesthesia 2010; Vol. 57, issue 2:149-66.
96. Turk DC, Dworkin RH, Revicki D, Harding G, Burke LB, Cella D, et al. Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain. Pain 2008;137(2):276-85.
97. Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, et al. Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Pain 2008;139(3):485-93.
98. Verdugo RJ, Ochoa JL. "Sympathetically maintained pain" I. Phentolamine block questions the concept. Neurology 1994;44:1003-10.
99. Verdugo RJ, Campero M, Ochoa JL. Phentolamine sympathetic block in painful polyneuropathies. II. Further questioning of the concept of "sympathetically maintained pain". Neurology 1994;44:1010-14.
100. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-5.
101. Cepeda MS, Lau J, Carr DB. Defining the therapeutic role of local anesthetic sympathetic blockade in complex regional pain syndrome: a narrative and systematic review. Clinical Journal of Pain 2002;18(4):216-33.
102. Cepeda S, Carr D. Local anesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI:]
103. Cepeda MS, Carr DB, Lau J. Local anaesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI:]